Faculty

Institution

Unit

Venue

Jeffrey S. Freeman

Philadelphia College of Osteopathic Medicine

Affiliations

Division Of Research

Center For Chronic Disorders Of Aging

Center for Chronic Disorders of Aging

Division Of Endocrinology And Metabolism

Philadelphia College of Osteopathic Medicine

NoneJeffrey S. Freeman is currently serving as a Center For Chronic Disorders Of Aging faculty at Philadelphia College of Osteopathic Medicine.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Jeffrey S. Freeman

Philadelphia College of Osteopathic Medicine

You can click a keyword to filter the displayed items

diabetes medicine diabetes mellitus diabetes management diabetes therapies diabetes research insulin management diabetic medicine pharmacology diabetes care endocrinology chronic diseases public health health sciences preventive healthcare treatment and prevention cardiovascular disease molecular pharmacology therapeutic targets clinical research metabolic syndrome medicinal research pharmacological research peptides osteopathic medicine pharmacotherapy psychoneuroendocrinology preventive medicine symptom management intensive care clinical lipidology peptide science pediatric diabetes insulin delivery key site pharmacoepidemiology clinical pharmacology novel therapies remedial action molecular basis diabetes epidemiology bone disease osteopathy disease management peptide therapeutics g protein-coupled receptor older adults insulin analog therapy physiologic insulin secretion insulin-independent agents potential role potential drug interactions clinical pharmacology review incretin hormones pharmacological basis current treatment algorithms primary care physicians practical solutions clinical challenges incretin mimetics management strategies glycemic control

Notable Scholarly Works

Notable Federal Grants

Collaborators

You May Delay, but Time Will Not. Beta Cells Lost Are Never Found Again: A Case for Timely Initiation of Basal Insulin in Type 2 Diabetes. Postgraduate Medicine (2024)

Susan RendaJeffrey Freeman

basal insulinmedicineendocrinologydiabetestimely initiation

Management of Hypoglycemia in Older Adults With Type 2 Diabetes. Postgraduate Medicine (2019)

Jeffrey Freeman

medicinediabetes therapiesdiabetes carediabetes managementinsulin managementdiabetes researcholder adultsdiabetesdiabetic medicinediabetes mellitus

Hot Topics in Primary Care: Considerations in the Selection of Antihyperglycemic Therapy for Older Patients With Type 2 Diabetes Mellitus: A Focus on Newer Therapies.. PubMed (2015)

Clinical Decision Making in Diabetes: Use of Glucagon-Like Peptide-1 (Glp-1) Receptor Agonists in Clinical Practice (Where, When, and Which?)–Introduction. Osteopathic Family Physician (2013)

Evidence From Randomized Clinical Trials Demonstrating Improved Glycemic Control With Glp-1 Receptor Agonists When Used With Other Agents vs Other Combination Therapy Strategies. Osteopathic Family Physician (2013)

Initial Combination Therapy for Patients With Type 2 Diabetes Mellitus: Considerations for Metformin Plus Linagliptin. Drugs in Context (2013)

Review of Insulin-Dependent and Insulin-Independent Agents for Treating Patients With Type 2 Diabetes Mellitus and Potential Role for Sodium-Glucose Co-Transporter 2 Inhibitors. Postgraduate Medicine (2013)

Jeffrey S. Freeman

medicinediabetes carediabetes managementdiabetesdiabetes mellitusinsulin deliveryinsulin-independent agentscardiovascular diseasepharmacologyanesthesiologykey sitediabetes researchdiabetic medicinediabetes therapiesendocrinologymetabolic syndromeinsulin managementmolecular pharmacologypotential roledrug metabolism

Common Patient Concerns About the Use of Glucagon-Like Peptide-1 Receptor Agonists in Diabetes Mellitus Management.. PubMed (2012)

Jeffrey S FreemanJames R GavinCraig W Spellman

pharmacologyurologyreceptorsmedicinepeptide sciencediabetes therapiespeptide therapeuticsdiabetes managementdiabetes mellitus managementchronic diseasesinsulin managementcommon patient concernspeptidesdiabetesg protein-coupled receptormedicinal researchtherapeutic targetsdiabetes mellitus

Improving Glucagon-Like Peptide-1 Dynamics in Patients With Type 2 Diabetes Mellitus.. PubMed (2012)

Jeffrey S Freeman

systems biologydiabetesdiabetes mellituspeptides

What Have We Learned About the Treatment of Type 2 Diabetes? the Evolving Paradigms. American Journal of Therapeutics (2012)

1
2
3
10 / page

Jeffrey S. Freeman

Philadelphia College of Osteopathic Medicine

Affiliations

Division Of Research

Center For Chronic Disorders Of Aging

Center for Chronic Disorders of Aging

Division Of Endocrinology And Metabolism

Philadelphia College of Osteopathic Medicine

NoneJeffrey S. Freeman is currently serving as a Center For Chronic Disorders Of Aging faculty at Philadelphia College of Osteopathic Medicine.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Jeffrey S. Freeman

Philadelphia College of Osteopathic Medicine

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

You May Delay, but Time Will Not. Beta Cells Lost Are Never Found Again: A Case for Timely Initiation of Basal Insulin in Type 2 Diabetes. Postgraduate Medicine (2024)

Susan RendaJeffrey Freeman

basal insulinmedicineendocrinologydiabetestimely initiation

Management of Hypoglycemia in Older Adults With Type 2 Diabetes. Postgraduate Medicine (2019)

Jeffrey Freeman

medicinediabetes therapiesdiabetes carediabetes managementinsulin managementdiabetes researcholder adultsdiabetesdiabetic medicinediabetes mellitus

Hot Topics in Primary Care: Considerations in the Selection of Antihyperglycemic Therapy for Older Patients With Type 2 Diabetes Mellitus: A Focus on Newer Therapies.. PubMed (2015)

Clinical Decision Making in Diabetes: Use of Glucagon-Like Peptide-1 (Glp-1) Receptor Agonists in Clinical Practice (Where, When, and Which?)–Introduction. Osteopathic Family Physician (2013)

Initial Combination Therapy for Patients With Type 2 Diabetes Mellitus: Considerations for Metformin Plus Linagliptin. Drugs in Context (2013)

Jeffrey S. Freeman

Common Patient Concerns About the Use of Glucagon-Like Peptide-1 Receptor Agonists in Diabetes Mellitus Management.. PubMed (2012)

Jeffrey S FreemanJames R GavinCraig W Spellman

Improving Glucagon-Like Peptide-1 Dynamics in Patients With Type 2 Diabetes Mellitus.. PubMed (2012)

Jeffrey S Freeman

systems biologydiabetesdiabetes mellituspeptides

What Have We Learned About the Treatment of Type 2 Diabetes? the Evolving Paradigms. American Journal of Therapeutics (2012)

1
2
3
10 / page